Donau Invest has backed the restructuring plan for Germany-based pharmaceutical company Curasan, which will see the company de-listed and taken over by Donau Invest, subject to creditor approval of the plan.
Charcoal and natural additives company saw final bids from two banks and one direct lender
VCs including the Swiss Entrepreneurs Fund, BtoV and Ringier Digital Ventures also participated
Around 40 existing and new LPs, including British Patient Capital and the EIF, participated
Fund will invest in buyouts, recapitalisations and carve-outs of both profitable and underperforming businesses